LFMD News and Press, LifeMD Inc.

2026-03-11 15:39:20 ET LifeMD, Inc.'s ( LFMD ) sustained dip for much of the past year has opened up a bullish entry point for prospective investors, with the company now swapping hands at its lowest multiple to trailing twelve months sales ("TTM"). TTM stood at $194.1 million as of...

2026-03-10 11:47:51 ET More on LifeMD LifeMD: Still My Favorite Bargain On The Market LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships LifeMD rises on Q4 2025 beats, 2026 revenue guidance midpoint...

2026-03-09 18:39:17 ET More on LifeMD LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript LifeMD, Inc. 2025 Q4 - Results - Earnings Call Presentation LifeMD: Still My Favorite Bargain On The Market LifeMD rises on Q4 2025 beats, 2026 revenue guidance midpoin...

2026-03-09 18:37:59 ET LifeMD, Inc. (LFMD) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC, Research...

2026-03-09 17:30:19 ET More on LifeMD LifeMD: Still My Favorite Bargain On The Market LifeMD: Pure Telehealth Play With In-House Pharmacy Integration LifeMD GAAP EPS of -$0.04 beats by $0.02, revenue of $46.9M beats by $1.29M GoodRx, LifeMD gain on offerings ...

2026-03-09 16:12:40 ET More on LifeMD LifeMD: Still My Favorite Bargain On The Market LifeMD: Pure Telehealth Play With In-House Pharmacy Integration GoodRx, LifeMD gain on offerings for Novo’s Wegovy pill Seeking Alpha’s Quant Rating on LifeMD ...

Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million. Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million. Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patien...

New Fortress Energy Inc. (NFE) is expected to report $-1.08 for Q4 2025 Design Therapeutics Inc. (DSGN) is expected to report $-0.38 for Q4 2025 Beta Technologies Inc. Class A (BETA) is expected to report $-0.52 for Q4 2025 Yext Inc. (YEXT) is expected to report $0.06 for Q4 2026 ...

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March: Mizuho Securities Healthcare Technology Con...

2026-02-26 02:21:25 ET Back in September 2025, I wrote an article on LifeMD ( LFMD ) and assigned my first ever Strong Buy rating. I saw LifeMD as an underappreciated telehealth company with a similar business model to Hims & Hers Health ( HIMS ) but at a much cheaper pr...